newsfilter
← Latest News
FDA Approved Drugs·

Approval of Tevimbra, Bla #761417

Approval Date: 12/26/2024; Drug Name: Tevimbra, Bla #761417; Active Ingredients: TISLELIZUMAB-JSGR; Company: Beigene; Submission Status: Approval; Application Number: 761417

Company
BEIGENE
Keywords
BEIGENE